Abstract: A device array substrate is provided and includes a flexible base, a pixel island, and a connection line. The pixel island is disposed on the flexible base, and at least one edge of the pixel island is provided with at least one opening. The connection line enters the pixel island via the opening. A display device is also provided and includes the device array substrate.

Abstract: Disclosed are a quinoline compound and the use thereof. The quinoline compound is a compound as represented by formula (I), formula (II) or formula (III), a pharmaceutically acceptable salt thereof, a solvate thereof, a stereoisomer thereof, a tautomer thereof, a prodrug thereof, a metabolite thereof, or an isotope compound thereof.

Abstract: Disclosed are a crystalline form of a nitrogen-containing heterocyclic compound, a preparation method therefor and use thereof. The present invention provides crystalline form C of compound 1, and a preparation method therefor, a composition thereof and use thereof in the preparation of medicaments are disclosed. The crystalline form is good in stability and high in bioavailability.

Abstract: A stretchable pixel array substrate includes a base, pixel structures, and a wiring. The base has first regions and a second region. The pixel structures are respectively disposed on the first regions of the base. The wiring is disposed on the second region of the base. Curved segments of the wiring include a first curved segment and a second curved segment. One of the pixel structures is disposed on one of the first regions. The first curved segment is disposed between the one of the pixel structures and the second curved segment. A distance A exists between a first curved portion and a second curved portion of the first curved segment in a first direction, a distance B exists between a first curved portion and a second curved portion of the second curved segment in the first direction, and A>B.

Abstract: A device panel includes a substrate, electronic devices, and first signal lines. The substrate is provided with a first bending area and a non-bending area outside the first bending area. The substrate is adaptable for bending along a first bending line in the first bending area. The electronic devices are disposed on the substrate, and include first electronic devices located in the non-bending area and second electronic devices located in the first bending area. The first signal lines extend in a first direction, and respectively connect the electronic devices in series. The first bending line is perpendicular to the first direction. Two junctions between any one of the second electronic devices and one of the first signal lines are located on two opposite sides of the any one of the second electronic devices in an axial direction of the first bending line.

Abstract: A school admission prediction system and method are provided. The system includes a user interface for receiving personal data from an applicant, including academic and activity data. A data acquisition module connected to the user interface acquires this personal data. A data preprocessing module connected to the data acquisition module preprocesses the academic and activity data. An attribute selection module connected to the data preprocessing module extracts multiple attributes from the preprocessed data. A machine learning model generates an evaluation report based on the extracted attributes. This report includes a prediction of whether the applicant will be admitted to the school. The system also includes a loss calculation module for evaluating the performance of the machine learning model and optimizing its parameters based on the evaluation results. The method and system provide a reliable and efficient way to predict school admissions, helping applicants to better prepare their applications.

Abstract: Provided are an ROR?t modulator, and a preparation method therefor and an application thereof. The ROR?t modulator is selected from a compound represented by formula I, and a pharmaceutically acceptable salt, solvate, solvate of pharmaceutically acceptable salt, metabolite or prodrug thereof. The compound has inhibitory activity on ROR?t, and can effectively inhibit an ROR?t protein receptor, thereby regulating the differentiation of Th17 cells, inhibiting generation of IL-17, and then treating ROR?t-mediated relevant autoimmune diseases.

Abstract: Provided are a quinazoline compound and an application thereof. Specifically provided is a quinazoline compound as shown in formula I. The compound is novel in structure and has a good inhibitory effect on cell factors TNF-?, IL-6, and IL-I?.

Abstract: A display device includes: a substrate, a plurality of pixel islands, and a plurality of traces. The substrate is stretchable. The plurality of pixel islands are disposed over the substrate. The plurality of traces respectively connect two adjacent pixel islands of the plurality of pixel islands, and each of the traces extends in a first main direction and then extends in a second main direction through a turning angle.

Abstract: An application of a compound having a structure represented by chemical formula 1, a pharmaceutically acceptable salt thereof, a solvate thereof, a solvate of the pharmaceutically acceptable salt thereof, or a crystal form thereof, in particular an application thereof in the preparation of an inhibitory drug targeting an ErbB2 mutant. The provided compound has inhibitory activity against the ErbB2 mutant, and can effectively inhibit proliferation of ErbB2 mutation tumor cells.

Abstract: A transparent electronic device includes an organic film, an amorphous transparent oxycarbide layer, and a matrix layer. The organic film includes a polymer containing carboxyl groups (—COOH). The amorphous transparent oxycarbide layer is disposed on the organic film and consists of a metal element, carbon element, oxygen element and an additional element. The metal element is selected from molybdenum (Mo), indium (In), tin (Sn), zinc (Zn), cadmium (Cd) and a combination thereof. An atomic number percentage of the additional element is equal to or greater than 0%, and is less than the least of an atomic number percentage of the metal element, an atomic number percentage of the oxygen element and an atomic number percentage of the carbon element. The matrix layer is disposed on the amorphous transparent oxycarbide layer. A manufacturing method of a transparent electronic device is also provided.

Abstract: A display device, including a flexible substrate, multiple lighting units, and multiple signal lines, is provided. The lighting units and the signal lines are located on the flexible substrate, and the signal lines are respectively electrically connected to the lighting units. Each signal line includes multiple first conductive patterns, at least one second conductive pattern, and at least one third conductive pattern. The first conductive patterns are located on the flexible substrate. The second conductive pattern is located on the first conductive patterns, and two ends of each second conductive pattern are respectively connected to two first conductive patterns. In a stretched state, the two first conductive patterns twist the commonly connected second conductive pattern. The third conductive pattern is superimposed on the second conductive pattern.

Abstract: A display apparatus, including a display panel and a flexible circuit board, is provided. The display panel has a first side and a second side adjacent to each other. The flexible circuit board includes a first part and a second part connected to each other. The first part is electrically bonded to the first side of the display panel. The second part is electrically bonded to the second side of the display panel. The first part of the flexible circuit board is bent along a first bending axis. The second part of the flexible circuit board is bent along a second bending axis. The flexible circuit board is provided with an opening, and an intersection of the first bending axis and the second bending axis overlaps with the opening. A method of fabricating the display apparatus is also provided.

Abstract: A salt of a nitrogen-containing fused heterocyclic compound or a crystal form thereof, and a preparation method therefor, a pharmaceutical composition thereof, and a use thereof, in particular, a salt of compound I as shown below or a crystal form thereof, and a preparation method, a pharmaceutical composition and a use. The salt of compound I or the crystal form thereof exhibits at least one of the following advantages: improved bioavailability, great mechanical properties, improved chemical stability, excellent fluidity, great compressibility, and improved dissolution characteristics.

Abstract: Provided is the carbonyl heterocyclic compound shown in formula (I) or a pharmaceutically acceptable salt thereof, capable of being used as a compound having a targeted lanthionine synthetase C-like protein 2 pathway and being used for the treatment of various conditions, including infectious diseases, autoimmune diseases, diabetes, and chronic inflammatory diseases.

Abstract: A device array substrate is provided and includes a flexible base, a pixel island, and a connection line. The pixel island is disposed on the flexible base, and at least one edge of the pixel island is provided with at least one opening. The connection line enters the pixel island via the opening. A display device is also provided and includes the device array substrate.

Abstract: A transparent electronic device includes an organic film, an amorphous transparent oxycarbide layer, and a matrix layer. The organic film includes a polymer containing carboxyl groups (—COOH). The amorphous transparent oxycarbide layer is disposed on the organic film and consists of a metal element, carbon element, oxygen element and an additional element. The metal element is selected from molybdenum (Mo), indium (In), tin (Sn), zinc (Zn), cadmium (Cd) and a combination thereof. An atomic number percentage of the additional element is equal to or greater than 0%, and is less than the least of an atomic number percentage of the metal element, an atomic number percentage of the oxygen element and an atomic number percentage of the carbon element. The matrix layer is disposed on the amorphous transparent oxycarbide layer. A manufacturing method of a transparent electronic device is also provided.

Abstract: A quinazoline compound as shown in formula I, and a pharmaceutically acceptable salt, solvate, prodrug, metabolite or isotopic compound thereof having a good inhibiting effect on a KRAS mutant protein.

Abstract: A stretchable pixel array substrate includes a base, pixel structures, and a wiring. The base has first regions and a second region. The pixel structures are respectively disposed on the first regions of the base. The wiring is disposed on the second region of the base. Curved segments of the wiring include a first curved segment and a second curved segment. One of the pixel structures is disposed on one of the first regions. The first curved segment is disposed between the one of the pixel structures and the second curved segment. A distance A exists between a first curved portion and a second curved portion of the first curved segment in a first direction, a distance B exists between a first curved portion and a second curved portion of the second curved segment in the first direction, and A>B.

Abstract: The present invention provides a use of a nitrogen-containing saturated heterocyclic compound.